Health knowledge made personal
Join this community!
› Share page:
Search posts:

Nexus Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Benztropine Mesylate Injection, USP 2 mg/2 mL (1 mg/mL), in 2 m

Posted Aug 02 2013 1:06pm
Nexus Pharmaceuticals Inc. is voluntarily recalling two lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the potential presence of visible particulate matter in the vials. This recall is being conducted at the user level.
Post a comment
Write a comment:

Related Searches